XML 32 R22.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Inventories (Tables)
6 Months Ended
Jun. 30, 2024
Inventory Disclosure [Abstract]  
Schedule of Inventory, Current
At June 30, 2024 and December 31, 2023, the Company's net inventories consisted of the following:
June 30, 2024December 31, 2023
Raw materials and work in process$12,684,573 $12,619,092 
Consigned inventory185,658 149,701 
Finished goods3,300,414 4,645,098 
Total inventories16,170,646 17,413,891 
less non-current inventories(11,868,487)(12,804,529)
Total inventories classified as current$4,302,159 $4,609,362 
Schedule of Inventory, Noncurrent
At June 30, 2024 and December 31, 2023, the Company's non-current inventories consisted of the following:
June 30, 2024December 31, 2023
Vibativ Raw Materials$6,781,071 $6,611,426 
Kristalose Raw Materials2,840,114 3,263,516 
Vaprisol Raw Materials1,173,442 1,170,641 
Sancuso Raw Materials536,237 574,502 
Caldolor Raw Materials31,489 — 
Acetadote Raw Materials13,474 33,678 
Ifetroban Raw Materials203,383 203,383 
Vibativ Finished Goods92,734 810,454 
Caldolor Finished Goods98,268 67,307 
Acetadote Finished Goods28,653 — 
Omeclamox69,622 69,622 
Total inventories classified as non-current$11,868,487 $12,804,529